• Je něco špatně v tomto záznamu ?

Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development

A. Girija, M. Vijayanathan, S. Sreekumar, J. Basheer, TG. Menon, RE. Krishnankutty, EV. Soniya

. 2022 ; 15 (2) : 265-291. [pub] -

Jazyk angličtina Země Spojené arabské emiráty

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019513

The emergence of communicable and non-communicable diseases has posed a health challenge for millions of people worldwide and is a major threat to the economic and social development in the coming century. The occurrence of the recent pandemic, SARS-CoV-2, caused by lethal severe acute respiratory syndrome coronavirus 2, is one such example. Rapid research and development of drugs for the treatment and management of these diseases have become an incredibly challenging task for the pharmaceutical industry. Although, substantial attention has been paid to the discovery of therapeutic compounds from natural sources having significant medicinal potential, their synthesis has made a slow progress. Hence, the discovery of new targets by the application of the latest biotechnological and synthetic biology approaches is very much the need of the hour. Polyketides (PKs) and non-ribosomal peptides (NRPs) found in bacteria, fungi and plants are a diverse family of natural products synthesized by two classes of enzymes: polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS). These enzymes possess immense biomedical potential due to their simple architecture, catalytic capacity, as well as diversity. With the advent of the latest in-silico and in-vitro strategies, these enzymes and their related metabolic pathways, if targeted, can contribute highly towards the biosynthesis of an array of potentially natural drug leads that have antagonist effects on biopolymers associated with various human diseases. In the face of the rising threat from multidrug-resistant pathogens, this will further open new avenues for the discovery of novel and improved drugs by combining natural and synthetic approaches. This review discusses the relevance of polyketides and non-ribosomal peptides and the improvement strategies for the development of their derivatives and scaffolds, and how they will be beneficial for future bioprospecting and drug discovery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019513
003      
CZ-PrNML
005      
20220804135726.0
007      
ta
008      
220720s2022 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1874467214666210319145816 $2 doi
035    __
$a (PubMed)33745440
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Girija, Aiswarya $u Department of Transdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India $u Institute of Biological Environmental Rural Sciences (IBERS), Aberystwyth University, United Kingdom
245    10
$a Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development / $c A. Girija, M. Vijayanathan, S. Sreekumar, J. Basheer, TG. Menon, RE. Krishnankutty, EV. Soniya
520    9_
$a The emergence of communicable and non-communicable diseases has posed a health challenge for millions of people worldwide and is a major threat to the economic and social development in the coming century. The occurrence of the recent pandemic, SARS-CoV-2, caused by lethal severe acute respiratory syndrome coronavirus 2, is one such example. Rapid research and development of drugs for the treatment and management of these diseases have become an incredibly challenging task for the pharmaceutical industry. Although, substantial attention has been paid to the discovery of therapeutic compounds from natural sources having significant medicinal potential, their synthesis has made a slow progress. Hence, the discovery of new targets by the application of the latest biotechnological and synthetic biology approaches is very much the need of the hour. Polyketides (PKs) and non-ribosomal peptides (NRPs) found in bacteria, fungi and plants are a diverse family of natural products synthesized by two classes of enzymes: polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS). These enzymes possess immense biomedical potential due to their simple architecture, catalytic capacity, as well as diversity. With the advent of the latest in-silico and in-vitro strategies, these enzymes and their related metabolic pathways, if targeted, can contribute highly towards the biosynthesis of an array of potentially natural drug leads that have antagonist effects on biopolymers associated with various human diseases. In the face of the rising threat from multidrug-resistant pathogens, this will further open new avenues for the discovery of novel and improved drugs by combining natural and synthetic approaches. This review discusses the relevance of polyketides and non-ribosomal peptides and the improvement strategies for the development of their derivatives and scaffolds, and how they will be beneficial for future bioprospecting and drug discovery.
650    12
$a COVID-19 $7 D000086382
650    _2
$a vyvíjení léků $7 D000076722
650    _2
$a lidé $7 D006801
650    _2
$a peptidy $x farmakologie $x terapeutické užití $7 D010455
650    12
$a polyketidy $x chemie $x metabolismus $x farmakologie $7 D061065
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a farmakoterapie COVID-19 $7 D000093485
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vijayanathan, Mallika $u Department of Transdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India $u Biology Centre - Institute of Plant Molecular Biology, Czech Academy of Sciences, České Budějovice, 370 05, Czech Republic
700    1_
$a Sreekumar, Sweda $u Department of Transdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India $u Research Centre, University of Kerala, India
700    1_
$a Basheer, Jasim $u School of Biosciences, Mahatma Gandhi University, PD Hills, Kottayam, Kerala, India $u Department of Cell Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacky University, Olomouc, Czech Republic
700    1_
$a Menon, Tara G $u Department of Transdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India
700    1_
$a Krishnankutty, Radhakrishnan E $u School of Biosciences, Mahatma Gandhi University, PD Hills, Kottayam, Kerala, India
700    1_
$a Soniya, Eppurathu V $u Department of Transdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala, India
773    0_
$w MED00180210 $t Current molecular pharmacology $x 1874-4702 $g Roč. 15, č. 2 (2022), s. 265-291
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33745440 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135719 $b ABA008
999    __
$a ok $b bmc $g 1822917 $s 1170756
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 15 $c 2 $d 265-291 $e - $i 1874-4702 $m Current molecular pharmacology $n Curr Mol Pharmacol $x MED00180210
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...